Cargando…
Heterogeneity of lipidomic profiles among lung cancer subtypes of patients
Lung cancer is a leading cause of cancer‐related deaths with an increasing incidence and poor prognoses. To further understand the regulatory mechanisms of lipidomic profiles in lung cancer subtypes, we measure the profiles of plasma lipidome between health and patients with lung cancer or among pat...
Autores principales: | Lv, Jiapei, Gao, Danyan, Zhang, Yong, Wu, Duojiao, Shen, Lihua, Wang, Xiangdong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156354/ https://www.ncbi.nlm.nih.gov/pubmed/29999584 http://dx.doi.org/10.1111/jcmm.13782 |
Ejemplares similares
-
Trans‐omic profiling between clinical phenoms and lipidomes among patients with different subtypes of lung cancer
por: Zhu, Zhenhua, et al.
Publicado: (2020) -
Is the clinical lipidomics a potential goldmine?
por: Zhang, Linlin, et al.
Publicado: (2018) -
Values of integration between lipidomics and clinical phenomes in patients with acute lung infection, pulmonary embolism, or acute exacerbation of chronic pulmonary diseases: a preliminary study
por: Gao, Danyan, et al.
Publicado: (2019) -
New focuses of clinical and translational medicine in 2020
por: Cheng, Xin, et al.
Publicado: (2020) -
Clinical lipidomics: a new way to diagnose human diseases
por: Lv, Jiapei, et al.
Publicado: (2018)